<DOC>
	<DOCNO>NCT01350544</DOCNO>
	<brief_summary>The investigator hypothesize participant treatment advocacy intervention show significantly good HIV treatment adherence participant no-treatment ( wait-list ) control group .</brief_summary>
	<brief_title>Treatment Advocacy Intervention HIV-Positive African Americans</brief_title>
	<detailed_description>Compared races/ethnicities , African Americans HIV low level engagement care , less likely antiretroviral treatment ( ART ) , likely delay care ART initiation ; ART less likely adherent high enough level treatment effective . We propose test innovative , culturally relevant treatment advocacy ( TA ) intervention African Americans HIV target social , cultural , structural issue contribute poor HIV treatment behavior . TA , sustain many community organization throughout HIV epidemic , never systematically evaluate . TA facilitate patient navigation medical system provide tailored HIV treatment education client-centered counseling improve adherence engagement care . TA target structural issue healthcare patient ' life advocate provider improve patient-provider relationship , recommend change treatment and/or provider ( need ) , refer patient mental health social service . TA particularly appropriate African Americans HIV , may mistrustful provider : conduct outside medical system safe , neutral community set individual associate patient ' healthcare . We develop culturally relevant TA program additionally discuss factor racism undermine healthcare Black community , acknowledge directly address patient ' medical mistrust stigma cop strategy arise response oppression . The specific aim ( 1 ) conduct randomize control trial examine effect culturally relevant TA program adherence among African Americans HIV ; ( 2 ) identify culturally relevant mediator explain effect treatment advocacy antiretroviral treatment adherence among African Americans HIV ( e.g. , improved behavioral adherence skill , cop stress/discrimination , mental health , patient satisfaction ; low level HIV misconception , internalize HIV stigma/homophobia , medical mistrust , substance use ) ; ( 3 ) explore culturally relevant moderator effect treatment advocacy antiretroviral treatment adherence among African Americans HIV ( e.g. , access care , discrimination , incarceration , poverty , social support , spirituality , trauma ) . A sample 200 African Americans HIV randomly assign TA intervention wait-list control group . Participants complete survey screen , 3- 6-months post-baseline , assess pre- , intra- , post-intervention effect adherence .</detailed_description>
	<criteria>18 year age old ; selfidentify African American Black client APLA ART miss least 1 dose past month currently detectable unknown HIV viral load ( viral load test within last six month ) . receive treatment advocacy last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>HIV</keyword>
	<keyword>Adherence</keyword>
	<keyword>African American/Black</keyword>
	<keyword>Disparities</keyword>
</DOC>